Combination Chemotherapy in Treating Patients With Germ Cell Tumors That Have Not Responded to Previous Cisplatin

NCT00002559 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

43

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer
Testicular Germ Cell Tumor

Interventions

BIOLOGICAL: filgrastim
DRUG: cisplatin
DRUG: ifosfamide
DRUG: paclitaxel

Sponsor

Memorial Sloan Kettering Cancer Center